DUSP1 and acquired polycythemia vera: In summary, our results suggest that DUSP1 addiction in the early stages of PV offers not only insights into the unique pathobiology, but also a potential therapeutic target, as inhibition of DUSP1 leading to JNK/p38MAPK hyperactivation may provide a strategy for elimination of the cycling JAK2V617F+ progenitors.